The Brain Mind and Memory Institute (BMMI) recently announced a new book by Professor Yury Kropotov. It is entitled Introduction to Biomarkers in Psychiatry. The book looks at the application of functional Neuromarkers in diagnosis, prognosis and treatment of psychiatric and psychological disorders. These disorders include ADHD, ASD, schizophrenia, OCD and Alzheimer’s disease. The book examines a number of cutting edge neurotherapy techniques for helping these conditions. These techniques include neurofeedback, transcranial Direct Current Stimulation (tDCS), Transcranial Magnetic Stimulation (TMS) and Deep Brain Stimulation (DBS).
“In the last two decades, research on functional neuromarkers in different conditions such as ADHD, schizophrenia and OCD, has provided a vast amount of empirical knowledge with clear indication that at least some of those neuromarkers are reliable and powerful tools in discriminating patients from healthy controls. Currently we face a decade of translation that focuses on application of functional neuromarkers for providing early detection of brain dysfunction, as well as a personalised care for patients with disease. The early detection of neuromarkers of mental illness in its turn requires development of preventive interventions.”
This book is a seminal text. It brings together important elements of an exciting new neuropsychologically based field for the assessment and treatment of psychological disorders. The importance was recently underscored by the Precision Medicine Initiative announced by USA President Obama.
As stated by Professor Kropotov, one of the most important aspects of the new psychological medicine in the identification of the biological markers for specific conditions. A biomarker (or neuromarker) refers to a measurable indicator of some biological state or condition. They are often measured and evaluated in order to examine normal biological processes, pathological processes, or pharmacologic responses to therapeutic interventions.
Professor Kropotov is the director of the laboratory for neurobiology of action programming at the Institute of the Human Brain (Russian Academy of Sciences) in St. Petersburg, and Professor at the Department of Psychology of the University for Science and Technology NTNU, in Trondheim, Norway. (Elsevier).
Both Professor Kropotov and Emeritus Professor Richard Clark, who is the Clinical Director of Brain Clinics Australia, are members of BMMI. Professors Kropotov and Clark are planning an Australian workshop for medical, psychological and other professionals on this emerging field in Adelaide, Sydney and Melbourne in April 2017.